Abstract:Objective: To investigate the possible association of functional C41657T and G4234C polymorphisms of XRCC2 genes with susceptibility of lung cancer in Northern Chinese population. Methods:The single nucleotide polymorphisms (SNP) in XRCC2 C41657T and G4234C were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 199 patients with lung cancer, and 200 healthy controls. The genotype and allele distribution were compared and their contribution to the risk of lung cancer were analyzed. Results: The genotype (CC, CT, and TT) and allele distribution of the XRCC2 C41657T and G4234C SNP in the patients with lung cancer was not significantly different compared with that in healthy controls (all P0.05). When the two XRCC2 SNP were combined, the haplotype distribution in lung cancer patients was not significantly different from that in healthy controls (P0.05). When stratified for histological type, smoking status, and age, compared with C/C genotype, combination of C/T and T/T genotypes of XRCC2 C41657T increased the risk of developing adenosquamous carcinoma (OR=2.95, 95%CI=1.15-7.59), and the individuals with C/T genotype of XRCC2 C41657T had the increased risk of developing lung cancer in non smokers (OR=2.12,95%CI=1.05-4.27). Compared with G/G genotype, the combination of G/C and C/C of XRCC2 G4234C and G/C genotype both increased the risk of developing small cell lung cancer (OR=2.82 and 2.82;95%CI=1.15-6.91 and 1.17-6.76). For old subjects (age≥60 years), the combination of G/C and C/C of G4234C and G/C genotype both increased the risk of developing lung cancer(OR=2.29 and 2.37;95%CI=1.11-4.72 and 1.16-4.88). Conclusions:For XRCC2 C41657T, both heterozygote and homozygote T carriers have the increased risk of developing adenosquamous carcinoma, the heterozygote CT carriers have the increased risk of developing lung cancer in non smokers. For G4234C, both heterozygote and homozygote C carriers have the increased risk of developing lung cancer in old subjects (age≥60 years) and of small cell lung cancer in Northern Chinese population.

TT Genotype of GNAS1 T393C Polymorphism Predicts Better Outcome of Advanced Non-Small Cell Lung Cancer Patients

CTLA-4 +49A>G Polymorphism is Associated with Advanced Non-Small Cell Lung Cancer Prognosis

Association between BCL-2 (-938C>A) polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated patients with advanced non-small cell lung cancer

ATG 16 L 1 rs 2241880 polymorphism predicts unfavorable clinical outcomes for colorectal cancer patients in the Chinese population

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients

Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer

Prognostic Significance of GSTP1, XRCC1 and XRCC3 Polymorphisms in Non-small Cell Lung Cancer Patients

Significance of Gastrokine-1 Polymorphism Rs4254535 as a Prognostic Marker and its Association with Clinical Characteristics in Chinese Lung Cancer Patients

Prognostic value of <i>GPC5</i> polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients

Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population.

Relationship Between Ctla-4+49a > G Polymorphism And The Risk Of Lung Adenocarcinoma In A Chinese Han Population

Genetic Variants of BCL2 Gene Predict Clinical Outcomes of Non-Small-cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy in a Chinese Population.

Polymorphisms of XRCC2 Gene Were Associated with Susceptibility of Lung Cancer

Prognostic Implications of the EGFR Polymorphism Rs763317 and Clinical Variables among Young Chinese Lung Cancer Population.

The Association of Genetic Polymorphisms of TNFα, TNF-R1, and TNF-R2 and Lung Cancer Chemotherapy Response

Genetic polymorphism of rs9564966 G > A on 13q22.1 predicts poor survival for Chinese patients with gastric cancer.

Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.

A Functional Polymorphism on Chromosome 15q25 Associated with Survival of Early Stage Non–Small-Cell Lung Cancer

Genetic variations in <i>SLC3A2/CD98</i> gene as prognosis predictors in non‐small cell lung cancer